Alzamend Neuro, Inc.

NASDAQ:ALZN

1.15 (USD) • At close December 23, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019201820172016
Operating Activities:
Net Income -9.948-14.878-12.362-5.047-4.41-4.862-0.932-1.57-0.069
Depreciation & Amortization 0.0510.0230.004000000
Deferred Income Tax 0-1.7070000000
Stock Based Compensation 0.9563.5834.4092.0321.8020.3960.2180.1140.041
Change In Working Capital 0.6712.3491.327-0.152-0.2991.23-1.347-0.05-0.006
Accounts Receivables 000000000
Inventory 000000000
Accounts Payables 01.7070.694000000
Other Working Capital 0.671-1.7070.634-0.152-0.2991.23-1.347-0.05-0.006
Other Non Cash Items 0.0011.7070.0090.4550.5622.1910.2270.0880.016
Operating Cash Flow -8.27-8.923-6.614-2.712-2.346-1.045-2.052-1.417-0.018
Investing Activities:
Investments In Property Plant And Equipment -0.1470-0.106000000
Acquisitions Net 000000000
Purchases Of Investments 005.375000000
Sales Maturities Of Investments 000000000
Other Investing Activites 00-5.3750.1010.1050.234-0.400
Investing Cash Flow -0.1470-0.1060.1010.1050.234-0.400
Financing Activities:
Debt Repayment 0.3000.400-0.36400
Common Stock Issued 1.2520.98918.9112.12.2880.2363.61500
Common Stock Repurchased 000000000
Dividends Paid 000000000
Other Financing Activities 2.1018.8554.052.2880.073-0.2591.4210.025
Financing Cash Flow 3.652018.8554.452.2880.3092.9921.4210.025
Other Information:
Effect Of Forex Changes On Cash 000000000
Net Change In Cash -4.765-8.92312.1351.8390.048-0.5020.540.0040.007
Cash At End Of Period 0.3765.14114.0641.9290.090.0430.5450.0050.007